A dynamically tunable terahertz human serum albumin biosensor based on Dirac semimetal nanozyme
Open Access
- 9 January 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1736291
Abstract
This study presents a tunable terahertz biosensor based on a hybrid architecture integrating bulk Dirac semimetal (BDS) with a photonic crystal for the label-free and highly sensitive detection of human serum albumin (HSA). The sensor exhibits a sharp Fano resonance resulting from the synergistic coupling between a defect mode and the BDS-mediated plasmonic response, with its resonance frequency being highly sensitive to variations in the refractive index of the sensing layer. Electric field simulations confirm significant field confinement and enhancement within the sensing region. The electrically tunable property of BDS allows dynamic reconfiguration of the sensor’s sensitivity by adjusting the Fermi level (0.1–0.4 eV), though at the expense of a reduced figure of merit (FOM) due to broader resonance peaks and increased loss, necessitating a balance in practical implementations. Structural parameter analysis reveals that sensitivity is inversely proportional to the sensing layer thickness and gradually decreases with increasing refractive index. The proposed biosensor achieves a reflection dip deeper than 99% near 1 THz, with an angular sensitivity of 247.5°/RIU for minute refractive index changes (Δn = 0.002), demonstrating high sensitivity and excellent electrical tunability. This platform demonstrates pioneering potential in integrating diagnostic-treatment nanotechnology. Due to the powerful local field enhancement generated by the BDS photonic crystal heterostructure, the imaging sensitivity of the contrast agent based on nanoenzymes has been significantly improved. Moreover, the profound local field enhancement and dynamic tunability of this platform suggest its potential for real-time monitoring and regulation of the catalytic efficiency of nanoenzymes, which could address a fundamental challenge in therapeutic applications. Combined with its inherent biocompatibility and strong detection capabilities, this framework proposes a viable pathway toward the clinical translation of nanoenzyme technology. Our work thus establishes a foundational platform that paves the way for future multifunctional theranostic systems capable of combining sensitive biomarker monitoring with enhanced therapeutic effects.Keywords
This publication has 36 references indexed in Scilit:
- Advancements in optical waveguide sensors through Fano resonanceOptics and Lasers in Engineering, 2025
- Human serum albumin-based cryogels as a biomimetic platform for 3D co-culture and drug-induced liver injury predictionInternational Journal of Biological Macromolecules, 2025
- Extreme sensitivity biosensing platform based on Fano resonance and graphene oxideSensors and Actuators B: Chemical, 2025
- Tetraphenylethylene-indole as a novel fluorescent probe for selective and sensitive detection of human serum albumin (HSA) in biological matrices and monitoring of HSA purity and degradationTalanta, 2024
- Goos-Hänchen shifts around Fano resonances in superconducting photonic crystals embedded with grapheneOptics & Laser Technology, 2024
- Two‐Dimensional Layered Topological Semimetals for Advanced Electronics and OptoelectronicsAdvanced Functional Materials, 2024
- Nephrotic syndrome: pathophysiology and consequencesJournal Of Nephrology, 2023
- Recent advancements in optical biosensors for cancer detectionBiosensors and Bioelectronics, 2022
- Albumin in Advanced Liver Diseases: The Good and Bad of a Drug!Hepatology, 2021
- Ellipsometry Studies of Protein Layers Adsorbed at Hydrophobic SurfacesJournal of Colloid and Interface Science, 1994